Tofacitinib Combined With Chidamide in R/R ENKTCL

Clinical trial NCT03598959 · UNKNOWN

Trial details

NCT number: NCT03598959
Sponsor: Sichuan University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Extranodal NK/T-cell Lymphoma

Start date: 2019-01-01
Primary completion: 2019-12-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.